A major obstacle to coordinated AI safety efforts is the fear of antitrust litigation. Labs are reluctant to agree on pacing or sharing safety techniques because it could be viewed as illegal collusion. Zvi Mowshowitz suggests a simple government action would be to provide an explicit antitrust waiver for such collaborations.

Top AI companies like OpenAI and Anthropic cannot unilaterally slow development, even with safety concerns. They fear that competitors or foreign adversaries would seize an insurmountable advantage, forcing them to seek government-led coordination to pace development safely.

A significant barrier to voluntary safety pacts among AI companies is antitrust law. An agreement to slow development could be prosecuted as illegal anti-competitive collusion, as it would limit the technology available to consumers. This makes government-led frameworks essential for any coordinated industry action.

Amidst regulatory clashes, the Trump administration is reportedly considering taking equity stakes in major labs like OpenAI and Anthropic. This potential move could be a negotiating tactic to gain more control over AI safety and development, representing a significant escalation in government oversight of the technology.

Frontier AI labs like OpenAI and Anthropic are not genuinely planning to slow development. Their public calls for regulation serve strategic purposes: virtue signaling, legal cover (CYA), and most importantly, 'monopoly masking'—pretending the market is more competitive than it is to avoid antitrust scrutiny of their emerging duopoly.

Acknowledging their safety plans might be inadequate, leaders from multiple frontier labs have begun to seriously entertain a coordinated slowdown. This represents a major shift, as they also explore legal "safe harbors" to collaborate on safety without triggering antitrust violations, breaking the frame of the current race.

Major AI companies are not solely seeking to stifle competition with regulation. They are also signaling an inability to self-regulate amidst intense competitive pressure, effectively asking external bodies to impose a mandatory safety floor that applies to everyone.

Major AI labs like Anthropic and OpenAI cannot legally form agreements to "pace" development without government approval. The Sherman Antitrust Act prohibits such collusion, which could be seen as forming a cartel, even if the stated intention is safety.

Instead of direct regulation, the government could act as a reluctant mediator for AI safety. By setting a deadline for labs to form their own collaborative safety pact, it creates a powerful incentive: if they fail, the government will impose 'heavy-handed' and likely suboptimal regulations, an outcome all parties want to avoid.